CAMP and systemic lupus erythematosus: Anti-natural LL37 antibodies have potential pathogenic effects in SLE, and this carbamylated LL37 can promote the production of anti-natural LL37 antibodies through activation of T helper cells and direct effects on B cell differentiation [12].